Orthofix Medical Inc. Board of Directors

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Mr. Massimo Calafiore

Mr. Massimo Calafiore

President, CEO, Director and Interim President of Global Spine

Ms. Julie B. Andrews

Ms. Julie B. Andrews

Chief Financial Officer

Ms. Jill Mason

Ms. Jill Mason

Chief Compliance & Risk Officer

Mr. Ehab M. Esmail

Mr. Ehab M. Esmail

Senior Vice President of Global Quality, Regulatory & Clinical Affairs

Ms. Stephanie Walsh

Ms. Stephanie Walsh

Chief Human Resources Officer

Ms. Julie D. Dewey

Ms. Julie D. Dewey

Chief Investor Relations & Communications Officer

Mr. Geoffrey C. Gillespie

Mr. Geoffrey C. Gillespie

VP & Corporate Controller

Ms. Aviva McPherron

Ms. Aviva McPherron

President of Global Operations & Quality

Mr. J. Andres Cedron

Mr. J. Andres Cedron

Chief Legal Officer & Corporate Secretary

Mr. Tyler P. Lipschultz

Mr. Tyler P. Lipschultz

President of Global Biologics

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.